Clinical Trial

Ascorbate in Myelodysplastic Syndrome

Name: Ascorbate in Myelodysplastic Syndrome — clinical trial record (NCT07283900)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: AIMS

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is an open-label, phase II clinical trial with safety run-in evaluating the safety, tolerability, and efficacy of IV HDA in combination with azacitidine for participants with MDS.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-12-11.

Status change: Not Yet Recruiting → Recruiting 2026-03-12

Trial Details

NCT Number	NCT07283900
Lead Sponsor	Prajwal Dhakal
Conditions	Myelodysplastic Syndromes
Enrollment	38 participants
Start Date	2026-03-11
Primary Completion	2028-05-01 (estimated)
Study Completion	2029-05-01 (estimated)
Updated on ClinicalTrials.gov	2026-03-16